ALHC vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 30, 2026

ALHC

48.6
AI Score
VS
CLOV Wins

CLOV

52.6
AI Score

Investment Advisor Scores

ALHC

49score
Recommendation
HOLD

CLOV

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ALHC CLOV Winner
Revenue 1.44B 1.36B CLOV
Net Income -24.38M -100.81M CLOV
Net Margin -1.7% -7.4% CLOV
Operating Income -36.21M -85.90M CLOV
ROE -7.2% -53.5% CLOV
ROA -4.4% -13.1% CLOV
Total Assets 559.66M 770.79M ALHC
Current Ratio 1.71 1.63 CLOV
Free Cash Flow -228,000 102.88M ALHC

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.